Table 2.

Factors increasing the risk of relapse

Clinical presentationSerologyTreatment related
GPAPR3-ANCA at presentationSteroid withdrawal
ENT involvementANCA positive after inductionImmunosuppressive withdrawal
Better renal function (creatinine <200 μmol/L)Rise in ANCA during treatmentLower cumulative CYC exposure
  • ANCA = antineutrophil cytoplasmic antibody; CYC = cyclophosphamide; ENT = ear, nose and throat; GPA = granulomatosis with polyangiitis; PR3 = proteinase 3